Partnerteam
Pharmacology, pharmacogenomics, drug discovery and design, drug therapy [126]
Projet
ANR Patho-Methylome – The role of lysine methylation in host-pathogen interactions
(EN) Jonathan Weitzman
Projet
FP7 Anti-Parasitic Drug Discovery in Epigenetics (A-ParaDDisE)
(EN) Raymond J. Pierce
Projet
FP7 Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug)
Gérald Spaeth
Projet
ANR TransLeish – Discovery of druggable protein kinases in the protozoan parasite Leishmania donovani using hit compounds identified by phenotypic screening
Najma Rachidi • Gérald Spaeth
Projet
Deciphering the regulation of human innate antimicrobial mechanisms to develop innovative immuno-stimulatory molecules
Brice Sperandio
Projet
Therapeutic potential of mycolactone surrogates
Caroline Demangel
Projet
Mycolactone of M. ulcerans and immunodulation
Caroline Demangel • Laure Guenin-Mace
Projet
Inhibitors of the 2’-deoxyribonucleotide N-hydrolase DNPH1, an enzyme involved in cellular growth and angiogenesis
Sylvie Pochet • Pierre Alexandr Kaminski
Projet
Antibiotic resistances and drug screening
Brigitte Gicquel
Projet
Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens
Brigitte Gicquel
Projet
Cyanobacterial bioactive compounds
Muriel Gugger
Projet
Innate immune response to C. trachomatis infection in the female genital tract
Yongzheng Wu
Outil
Optogenetic
Group
Groupe: Miria Ricchetti
Miria Ricchetti
Group